Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PPL
PPL Corp
PPL
|
+$304M |
| 2 |
SWN
Southwestern Energy Company
SWN
|
+$207M |
| 3 |
Biogen
BIIB
|
+$177M |
| 4 |
MON
Monsanto Co
MON
|
+$164M |
| 5 |
BNY
Bank of New York Mellon
BNY
|
+$153M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$412M |
| 2 |
Pfizer
PFE
|
+$283M |
| 3 |
Devon Energy
DVN
|
+$194M |
| 4 |
Valero Energy
VLO
|
+$187M |
| 5 |
Altria Group
MO
|
+$174M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.04% |
| 2 | Energy | 12.07% |
| 3 | Financials | 9.11% |
| 4 | Consumer Discretionary | 8.85% |
| 5 | Industrials | 8.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NXTM
1026
DELISTED
NxStage Medical Inc.
NXTM
| $9.22M | 0.02% |
645,761
+401,591
| +164% | +$6.8M |
|
1027
CALL
Marathon Petroleum
MPC
$102B
| $9.22M | 0.02% |
+176,300
| New | +$8.97M |
|
|
AMTD
1028
CALL
DELISTED
TD Ameritrade Holding Corp
AMTD
| $9.21M | 0.02% |
+250,000
| New | +$9.29M |
|
|
XENT
1029
DELISTED
Intersect ENT, Inc
XENT
| $9.2M | 0.02% |
321,259
-98,768
| -24% | -$2.59M |
|
1030
PUT
Kinder Morgan
KMI
$69B
| $9.19M | 0.02% |
239,300
-239,300
| -50% | -$9.99M |
|
|
NBIS
1031
Nebius Group N.V.
NBIS
$57.3B
| $9.17M | 0.02% |
602,555
-398,533
| -40% | -$7.28M |
|
1032
Invesco Mortgage Capital
IVR
$805M
| $9.16M | 0.02% |
63,964
-165,727
| -72% | -$25.9M |
|
1033
Tandem Diabetes Care
TNDM
$1.55B
| $9.15M | 0.02% |
84,379
-11,917
| -12% | -$1.48M |
|
|
ARGO
1034
DELISTED
Argo Group International Holdings, Ltd.
ARGO
| $9.11M | 0.02% |
206,968
-228,220
| -52% | -$9.47M |
|
|
PLCM
1035
DELISTED
POLYCOM INC
PLCM
| $9.1M | 0.02% |
795,597
-775,471
| -49% | -$10.1M |
|
|
EXCU
1036
DELISTED
Exelon Corporation
EXCU
| $9.07M | 0.02% |
200,000
| – | – |
|
|
DTV
1037
CALL
DELISTED
DIRECTV COM STK (DE)
DTV
| $9.07M | 0.02% |
+97,700
| New | +$8.83M |
|
|
CBD
1038
DELISTED
Companhia Brasileira de Distribuicao
CBD
| $9.06M | 0.02% |
382,931
-97,432
| -20% | -$2.88M |
|
|
TFCFA
1039
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
| $9.06M | 0.02% |
278,459
+13,248
| +5% | +$445K |
|
|
B
1040
Barrick Mining
B
$79.3B
| $9.02M | 0.02% |
845,720
+130,659
| +18% | +$1.59M |
|
|
CERN
1041
DELISTED
Cerner Corp
CERN
| $9.01M | 0.02% |
130,521
+103,837
| +389% | +$7.27M |
|
|
CONN
1042
DELISTED
Conn's Inc.
CONN
| $9.01M | 0.02% |
227,000
+58,763
| +35% | +$2.11M |
|
1043
KLA
KLAC
$237B
| $9.01M | 0.02% |
1,602,210
+1,274,010
| +388% | +$7.45M |
|
1044
Nike
NKE
$60.5B
| $9M | 0.02% |
166,694
-566,028
| -77% | -$29M |
|
|
CNW
1045
DELISTED
CON-WAY INC.
CNW
| $9M | 0.02% |
234,534
-590,883
| -72% | -$24.5M |
|
|
WBC
1046
DELISTED
WABCO HOLDINGS INC.
WBC
| $8.99M | 0.02% |
72,672
-159,441
| -69% | -$20.1M |
|
1047
Standard BioTools
LAB
$255M
| $8.98M | 0.02% |
371,214
+343,833
| +1,256% | +$10.9M |
|
|
HEES
1048
DELISTED
H&E Equipment Services
HEES
| $8.98M | 0.02% |
449,798
+243,033
| +118% | +$5.82M |
|
|
HBI
1049
DELISTED
Hanesbrands
HBI
| $8.97M | 0.02% |
269,370
-1,803
| -0.7% | -$59K |
|
1050
Accuray
ARAY
$32.4M
| $8.96M | 0.02% |
1,329,270
-335,790
| -20% | -$2.5M |
|
Similar funds
Israel Englander's Q2 2015 Portfolio in Review
As of Q2 2015, Israel Englander held 4,294 positions worth $52.9B, down 1.6% from $53.7B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Israel Englander's Q2 2015 filing shows 780 new, 1,199 increased, 1,223 reduced and 1,034 closed positions. Its largest new stake was Charter Communications: 575,958 shares worth $98.6M. The largest sale was Teva Pharmaceuticals, an estimated $412M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, down from 16% a quarter earlier, followed by Energy and Financials.
- Israel Englander's largest Q2 2015 buy was Charter Communications: 575,958 shares worth $98.6M.
- Israel Englander added most to PPL Corp in Q2 2015, an estimated $304M increase.
- Israel Englander's biggest Q2 2015 reduction was Teva Pharmaceuticals, cutting an estimated $412M.
- Israel Englander fully exited SALIX PHARMACEUTICALS LTD DEL in Q2 2015, selling an estimated $145M.
- Israel Englander's ten largest holdings make up 11% of its $52.9B portfolio in Q2 2015.
- Israel Englander opened 780 new positions and closed 1,034 in Q2 2015.
- Israel Englander's portfolio value fell 1.6% quarter-over-quarter to $52.9B.
Based on Millennium Management's 13F filing for Q2 2015, filed 14 Aug 2015.